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ABSTRACT 
Hyperparathyroidism is a common endocrine disorder characterized by hypersecretion of parathyroid hormones due to 
abnormal activity of one or more parathyroid glands. Several cardiac abnormalities have been reported due to 
hyperparathyroidism. In this case report, a case of cardiac arrest due to hyperparathyroidism and hypercalcemia is presented 
and discussed. A female patient, 73 years old, was admitted to surgical ward (SICU) with malignant goiter extending to the 
retrosternum. She was a known case of hyperparathyroidism and hypercalcemia. After the operation, the patient was shifted to 
SICU for further management. Suddenly, the patient had sudden cardiac arrest and was successfully resuscitated within 2 
minutes. The ECG showed a new Right Bundle Branch Block (RBBB) changes. Patient remained on ventilator, not obeying 
commands, and opened her eyes spontaneously with cough reflex. A week after, percutaneous tracheostomy was performed, 
and patient became hemodynamically stable, weaned from ventilator and allowed to breathe spontaneously. Although cardiac 
arrest is a rare complication, it should be expected by health care providers when dealing with patients with 
hyperparathyroidism and hypercalcemia. 
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yperparathyroidism (HPT) is a common 
endocrine disorder characterized by 
hypersecretion of parathyroid hormones due to 
abnormal activity of one or more parathyroid glands [1]. 
Parathyroid hormone (PTH) has a central role in 
maintaining the hemeostatis of serum calcium and 
phosphorus levels. In normal cases, when serum calcium 
levels drop, this triggers parathyroid gland to induce the 
secretion of parathyroid hormones, which accordingly 
triggers calcium resorption from the bones and raise serum 
calcium levels [2]. However, in the case of 
hyperparathyroidism, the overactivity of parathyroid 
glands causes abnormal secretion of parathyroid hormone 
which leads to abnormal clinical hypercalcemia [3].  
This condition usually occurs with patients who are 
above 65 years; however, it can also affect younger 
population [4]. The frequency of HPT is reported to be 1 in       
 
1000 individuals in general population. In addition, the 
ratio of this disease is equal between men and woman (1:1) 
[5]. There are two types of hyperparathyroidism, primary 
and secondary. In primary HPT, the cause of the disease is 
due to an enlargement in one or more parathyroid gland 
itself. About 85% of the cases are reported to be caused by 
parathyroid adenomas.  
However, other causes such as diffuse parathyroid 
hyperplasia and carcinoma are found in most of the 
remaining cases (around 15%) [6]. On the other hand, 
secondary hyperparathyroidism is resulted by the 
overactivity of parathyroid gland due to other conditions 
outside the gland itself which  initially cause the dropping 
in serum calcium levels [7]. The most common reported 
cause is kidney failure due to chronic renal insufficiency 
which accompanied by hypocalcaemia and 
hypophosphatemia. Other causes are vitamin D deficiency, 
calcium malabsorption and osteomalacia [8]. 
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The main sign of primary hyperparathyroidism is 
hypercalcemia which caused by the resorption of calcium 
from the bone, reduction of calcium excretion from the 
kidneys and the rise of the absorption of calcium by the 
bowl [9]. There are several complications that are reported 
to be associated with this condition including kidney 
stones, osteoporosis, and clinical symptoms of 
hypercalcemia [10]. However, recent studies have 
indicated other types of complications which are the 
cardiovascular diseases. Studies have found that primary 
HPT is associated with cardiac death, myocardial 
infarction, ventricular hypertrophy, disturbances in renin-
angiotensin system and functional changes in cardiac 
vascular wall [11]. In this case report, a rare case for a 
patient who experienced cardiac arrest due to primary 
hyperparathyroidism will be presented. 
CASE REPORT 
A female patient, 73 years old, was admitted to surgical 
ward (SICU) with malignant goiter extending to the 
retrosternum. She was admitted to rule out metastasis and 
for pre-operative assessment (goiter removal). She is a 
known case of non-insulin dependent diabetes mellitus, 
hypertension, coronary artery disease, hypothyroidism, 
hyperparathyroidism and hypercalcemia.  
Different examinations were done for the patient 
including CT scan, endocrinology test, echocardiogram 
etc. The CT scan found a left ventricular enlargement with 
retrosternal extension with absence of any cervical 
lymphadenopathy or pulmonary metastasis. In addition, 
Iodine 131 total body scintigraphy was performed and 
found an increase uptake in thyroid glands. 
Biochemistry test were also done and all the results 
were normal including serum creatinine, sodium, 
potassium etc. In addition, hematology test revealed the 
following: Hemoglobin (HB) 12.1 g/dl, Platelets (Plt) 
205000, Hct 38.5%. Other cardiac related investigations 
were also performed including echocardiogram, ECG and 
chest x-ray.  
The echocardiogram found a mild left ventricular 
(LV) dysfunction with ejection fraction (EF) of 47%, LV 
diastolic dysfunction, LV and left atrial enlargement and 
hypokinetic inferioposterior wall. In addition, the result of 
ECG indicated the presence of sinus rhythm and LV 
hypertrophy. Lastly, chest x-ray found the presence of 
cardiomegaly. Endocrinology examination was also done 
and the following results were found (table 1): 
Table 1 - Endocrinology test results 
Parameters The result Normal 
levels 
Parathyroid hormones 147 pg 15-65 pg 
Vitamin D 19 ng 20-80 ng 
Corrected calcium 2.89 mmol/L 2.1- 2.6 mmol/L 
Albumin 40 g/L 35- 50 g/L 
Free triidothyronine 2.5 pmol 3.4 -6 pmol 
Thyroid Stimulating 
Hormone (TSH) 
0.22 mIU /L 0.45- 4.5 mIU/L 
The patient went under general anesthesia for operation 
which took about 6 hours. The induction was smooth and 
the intubation was easy. The patient experienced one 
episode of hypotension needed ephedrine and received 2 
liters of crystalloids. After operation, she was shifted to 
SICU for further management.  
In SICU, the patient was given diprivan for sedation 
and remifentanyl for analgesia. In addition, labetalol was 
given to reduce the blood pressure and pamidronate 60 
mgs IV every 12 hours to treat hypercalcemia. On the day 
after, she weaned from ventilator and extubated. 
Suddenly at 18:00 pm, patient experienced sudden 
cardiac arrest and was successfully resuscitated within 2 
minutes. The ECG showed a new Right Bundle Branch 
Block (RBBB) changes. In addition, noradrenaline was 
started to maintain hemodynamics. On the day after, spiral 
CT chest showed minimal bilateral pleural effusion with 
no evidence of pulmonary embolism. After that, she had 
atrial fibrillation and was started on Amiodarone and 
digoxin. In addition, she also developed hypotension with 
atrial fibrillation and treated with DC shock. 
Two days later, echocardiogram was performed and it 
ruled-out any intracardiac thrombus with EF 65%. CT scan 
for the head was also done and showed minimal 
intraventicular hemorrhage with no active management by 
Neurosurgeon. Patient remained on ventilator, not obeying 
commands, and opened her eyes spontaneously with cough 
reflex. One week after, percutaneous tracheostomy was 
done and patient, then, became hemodynamically stable, 
weaned from noradrenaline and ventilator and allowed to 
breathe spontaneously with HME. 
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DISCUSSION 
Hyperparathyroidism is a condition in which 
parathyroid glands become overactive and secret abnormal 
levels of parathyroid hormones. In the case of primary 
hyperparathyroidism, the cause of this overactivity is due 
to an enlargement in the gland itself due to adenoma, 
hyperplasia, carcinoma etc. Parathyroid gland play central 
role in maintaining the balance of serum calcium and 
phosphorus levels. Therefore, once the gland become 
hyperactive, several complications could be expected. 
These complications include but not limited to 
osteoporosis, kidney stones, clinical hypercalcemia and 
multiple cardiovascular problems. In the last two decades, 
studies have focused on exploring the association between 
primary hyperparathyroidism and heart diseases [12].  
The main mechanism by which the cardiac 
abnormalities are established is through the followings. At 
the beginning, parathyroid hormones bind to PTH/PTHrp 
(receptor protein) on cardiomyocytes. This cause an 
increase in intracellular calcium levels which results in the 
activation of protein kinase C cascade. This activation 
causes a hypertrophic process to be initiated on the cardiac 
myocytes beside some other metabolic effects [13]. In 
addition to the hypertrophic effect, parathyroid hormones 
increase the chornotropic effect on cardiac cells and 
decrease the energy utilization which results in myocardial 
and valvular calcifications, diastolic dysfunction and 
cardiac hypertrophy [14]. Moreover, high calcium level 
along with high parathyroid hormones affects endothelial 
cell and cause a vascular wall dysfunction which 
consequently results in an increase in central blood 
pressure and worse the condition of hypertrophy [15].  
These complications have been reported in different 
studies. A study by Symone et al, reported the occurrence 
of left ventricular hypertrophy in patients with high levels 
of parathyroid hormones and hypercalcemia [16]. 
Similarly, another blinded study found that around 82% of 
primary hyperparathyroidism patients experienced LV 
hypertrophy before the operation [17]. In the same study, 
the investigators found a regression of hypertrophy of 
interventricular septum and cardiac posterior wall by - 6% 
and - 19% (P <0.05) after parathyroidectomy. The time 
takes for this regression to be completed is still uncertain. 
Some studies indicated that it takes not less than 2-3 
months to get full hypertrophy regression [18, 19]. 
However, other studies indicated no difference in the 
hypertrophic levels until 6 to 24 hours after 
parathyroidectomy [20, 21]. In addition, studies found that 
patients with symptomatic primary hyperparathyroidism 
are at significant high risk of mortality before and even 
after parathyroidectomy [22, 23]. 
In our study, the patient experienced a rare 
complication of pHPT which is cardiac arrest. Although it 
is a rare case, some other case reports have also reported 
this incidence. One study reported a case for a patient who 
presented to emergency department unconscious and 
experienced cardiac arrest. Later, they found the reason for 
the arrest which is hyperparathyroidism that resulted in 
thyroid storm-induced cardiac arrest [24]. Another case for 
a 47-years old patient was discussed by another study [25]. 
This patient had hyperparathyroidism which leads to 
complete atrioventicular block and cardiac arrest despite 
the initiation of anti-thyroid medications. This was 
considered a rare case since the common cardiac 
manifestation of HPT is atrial fibrillation, atrial flutter, 
sinus tachycardia, angina pectoris, heart failure or 
cardiomyopathy. However, a complete atrioventicular 
block and cardiac arrest are very rare complications. The 
mechanism that leads to cardiac arrest has been 
demonstrated in several studies. Both elevated calcium 
level and PTH exert a hypertrophic effect on cardiac cells 
and subsequently leads to cardiac abnormalities and 
possibly cardiac arrest [17]. In addition, other reports have 
found a relation between the use of beta-blocker and 
cardiac arrest by inducing a poor ejection fraction. 
Therefore, it has been recommended to use short acting 
beta blocker like Esmolol for hemodynamic monitoring 
[25]. 
CONCLUSION 
Hyperparathyroidism is characterized by abnormal levels 
of parathyroid hormones and calcium which causes 
different cardiac abnormalities. Although cardiac arrest is 
a rare complication, health care providers should be 
prepared to deal with such consequences. 
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